SOFIA (Bulgaria), January 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its non-consolidated net profit fell by an annual 26.6% to 32.4 million levs ($18.9 million/16.6 million euro) in 2018, following a drop in revenue.